DJ bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India
bonyf NV / Key word(s): Capital Increase/Expansion bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India 03-Jun-2025 / 17:28 CET/CEST =---------------------------------------------------------------------------------------------------------------------- bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India Knokke-Heist (Belgium), 3 June 2025, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, is proud to announce that Group Pharmaceuticals, a leading Indian oral health company, has become a significant stakeholder in bonyf NV. To date, Group Pharmaceuticals has acquired a total of 13.5% of bonyf's shares, marking a strong commitment to a long-term strategic partnership. This collaboration represents a major step forward in bonyf's global expansion and positions the company to accelerate its growth in the Indian market. Group Pharmaceuticals is a prominent player in India's oral healthcare sector, with a field force that directly reaches over 100,000 dentists every month. This outstanding market access creates a powerful platform for promoting bonyf's high-performance oral care products to dental professionals and their patients. As part of the partnership, Group Pharmaceuticals will also begin local production of selected bonyf-licensed products in India. This move ensures cost-effective manufacturing, regulatory alignment, and streamlined distribution across the region. Importantly, this alliance reinforces dentist-led product recommendations and builds strong brand trust among patients. In addition, both companies are committed to co-developing new oral care solutions tailored to the needs of the Indian market. Jean-Pierre Bogaert, CEO of bonyf, stated: "We view this as a very important collaboration. Group Pharmaceuticals' strong market presence and outstanding network in India will help us realize our international growth ambitions while ensuring that our products reach millions of new patients." bonyf sees this strategic investment and collaboration as a key driver for sustainable international growth. For more information, visit bonyf.com or contact investor@bonyf.com. bonyf's strengths -- Products with patented formulations -- Produced in Switzerland compliant with stringent international quality regulations -- Proven clinical efficacy -- Commercial presence in 37 countries -- Prospects for solid growth and rapid profitability -- A fast-growing oral and dental care market About bonyf Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market. For more information about bonyf and its innovative oral care products, please visit www.bonyf.com. bonyf Jean-Pierre Bogaert investor@bonyf.com
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Financial Wire News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
Language: English
Issuer: bonyf NV
Kalvekeetdijk 179, box 105
8300 Knokke-Heist
Belgium
Phone: +41 79 412 42 79
E-mail: president@bonyf.com
Internet: www.bonyf.com
ISIN: BE6333353298
EQS News ID: 2149994
End of Announcement - EQS News Service
=------------------------------------------------------------------------------------
2149994 03-Jun-2025 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=5f0f535be0839ba2a9b5d0a906fccb17
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2149994&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face
(END) Dow Jones Newswires
June 03, 2025 11:28 ET (15:28 GMT)
© 2025 Dow Jones News
